Healthcare testing services are invented, and developed in the laboratories. During pharmaceutical production and research and development, healthcare testing in labs is required at practically every stage including preclinical, clinical, and manufacturing. It is used to test raw materials and to perform an in-process quality control (IPQC) of dosage forms and finished products. Healthcare testing aids in assessing a medical product's safety, efficacy, stability, and dosage potency. Before releasing a product in the market, a healthcare testing laboratory can assist in testing to ensure that it is safe to use. Chemical testing, microbiological testing, toxicological testing, stability testing, and other services are just a few services that healthcare testing laboratories offer to guarantee the safety of medications and treatments.
Market Dynamics
Complex research and development procedures, stringent government regulations regarding product compliance, increasing product approvals by regulatory authorities, and launches of novel services and products are the major factors that are expected to drive the growth of the global healthcare testing services market over the forecast period.
Moreover, increasing number of funding initiatives by government and research organizations to provide funding to pharmaceutical and medical device manufacturing companies in order to develop drugs and diagnostic kits for the treatment of novel coronavirus, increasing research and development activities, and rising number of clinical trials owing to the COVID-19 outbreak are expected to create lucrative opportunities in the market. Many research organizations and government agencies are funding pharmaceutical and medical device manufacturing companies for the development of kits for diagnosis and drugs, and for the treatment of the novel coronavirus.
For instance, in April 2020, Moderna Inc., a clinical-stage biotechnology company, received US$ 483 million funding from the U.S. Biomedical Advanced Research and Development Authority (BARDA) for rapid development of Moderna’s mRNA vaccine candidate (mRNA-1273) against the SARS-CoV-2 coronavirus. The funding will be through Phase II and III clinical trials to United States Food and Drug Administration (FDA) licensure.
Key features of the study:
- This report provides an in-depth analysis of the global healthcare testing services market, provides market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global healthcare testing services market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Eurofins Scientific, PPD, Inc., Microbac Laboratories, Inc., ARL Bio Pharma, Inc., Consumer Product Testing Company, Inc., Element Materials Technology Ltd., Intertek Group plc, DYNALABS LLC., ADPEN Laboratories, Inc., Moderna Inc., ZYUS Life Sciences Inc., PCI Pharma Services, Perfectus Biomed, Alcami Corporation Inc., SGS SA, Predictive Laboratories, Lasa Supergenerics Ltd, Roche Diagnostics India, National Jewish Health, and Parexel International Corporation, and Pfizer Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global healthcare testing services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare testing services market
Detailed Segmentation:
- Global Healthcare Testing Services Market, By Service Type:
- Chemical Testing
- Microbiological Testing
- Toxicology Testing
- Stability Testing
- Others
- Global Healthcare Testing Services Market, By Product Type:
- Anti-viral Drugs
- HIV Drugs
- Fertility Drugs
- Anti-diabetic Drugs
- Respiratory Drugs
- Anticoagulants
- Medical Devices
- Pharmaceutical Packaging
- Others
- Global Healthcare Testing Services Market, By Development Stage:
- Preclinical
- Clinical
- Manufacturing
- Global Healthcare Testing Services Market, By End User:
- Pharmaceutical Industry
- Contract Research Organization
- Others
- Global Healthcare Testing Services Market, By Region:
- North America
- By Service Type
- Chemical Testing
- Microbiological Testing
- Toxicology Testing
- Stability Testing
- Others
- By Product Type
- Anti-viral Drugs
- HIV Drugs
- Fertility Drugs
- Anti-diabetic Drugs
- Respiratory Drugs
- Anticoagulants
- Medical Devices
- Pharmaceutical Packaging
- Others
- By Development Stage
- Preclinical
- Clinical
- Manufacturing
- By End User
- Pharmaceutical Industry
- Contract Research Organization
- Others
- By Country
- Latin America
- By Service Type
- Chemical Testing
- Microbiological Testing
- Toxicology Testing
- Stability Testing
- Others
- By Product Type
- Anti-viral Drugs
- HIV Drugs
- Fertility Drugs
- Anti-diabetic Drugs
- Respiratory Drugs
- Anticoagulants
- Medical Devices
- Pharmaceutical Packaging
- Others
- By Development Stage
- Preclinical
- Clinical
- Manufacturing
- By End User
- Pharmaceutical Industry
- Contract Research Organization
- Others
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Service Type
- Chemical Testing
- Microbiological Testing
- Toxicology Testing
- Stability Testing
- Others
- By Product Type
- Anti-viral Drugs
- HIV Drugs
- Fertility Drugs
- Anti-diabetic Drugs
- Respiratory Drugs
- Anticoagulants
- Medical Devices
- Pharmaceutical Packaging
- Others
- By Development Stage
- Preclinical
- Clinical
- Manufacturing
- By End User
- Pharmaceutical Industry
- Contract Research Organization
- Others
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Service Type
- Chemical Testing
- Microbiological Testing
- Toxicology Testing
- Stability Testing
- Others
- By Product Type
- Anti-viral Drugs
- HIV Drugs
- Fertility Drugs
- Anti-diabetic Drugs
- Respiratory Drugs
- Anticoagulants
- Medical Devices
- Pharmaceutical Packaging
- Others
- By Development Stage
- Preclinical
- Clinical
- Manufacturing
- By End User
- Pharmaceutical Industry
- Contract Research Organization
- Others
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Service Type
- Chemical Testing
- Microbiological Testing
- Toxicology Testing
- Stability Testing
- Others
- By Product Type
- Anti-viral Drugs
- HIV Drugs
- Fertility Drugs
- Anti-diabetic Drugs
- Respiratory Drugs
- Anticoagulants
- Medical Devices
- Pharmaceutical Packaging
- Others
- By Development Stage
- Preclinical
- Clinical
- Manufacturing
- By End User
- Pharmaceutical Industry
- Contract Research Organization
- Others
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Service Type
- Chemical Testing
- Microbiological Testing
- Toxicology Testing
- Stability Testing
- Others
- By Product Type
- Anti-viral Drugs
- HIV Drugs
- Fertility Drugs
- Anti-diabetic Drugs
- Respiratory Drugs
- Anticoagulants
- Medical Devices
- Pharmaceutical Packaging
- Others
- By Development Stage
- Preclinical
- Clinical
- Manufacturing
- By End User
- Pharmaceutical Industry
- Contract Research Organization
- Others
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Eurofins Scientific *
- Company Overview
- Material Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- PPD, Inc.
- Microbac Laboratories, Inc.
- ARL Bio Pharma, Inc.
- Consumer Product Testing Company, Inc.
- Element Materials Technology Ltd.
- Intertek Group plc
- DYNALABS LLC.
- ADPEN Laboratories, Inc.
- Moderna Inc.
- ZYUS Life Sciences Inc.
- PCI Pharma Services
- Perfectus Biomed
- Alcami Corporation Inc.
- SGS SA
- Predictive Laboratories
- Lasa Supergenerics Ltd
- Roche Diagnostics India
- National Jewish Health
- Parexel International Corporation
- Pfizer Inc.
“*” marked represents similar segmentation in other categories in the respective section.
